upregulated ECS contributes to hypertension and impaired autonomic function in this Ang II-dependent model; systemic CB1R blockade may be an effective therapy for Ang II-dependent hypertension and the associated metabolic syndrome. This evidence concerns the gene CNR1 and metabolic syndrome.